Regel Therapeutics
Biotechnology ResearchMassachusetts, United States11-50 Employees
Combining cutting edge science, experienced business leaders and innovators, Regel Therapeutics is leveraging its Targeted EpiEditing platform transform the lives of people living with severe genetic diseases.